By contrast, another recent study demonstrated that engagement with an app-based digital weight loss program created by clinicians and behavioral scientists significantly enhanced weight loss outcomes of patients being treated with incretin analogs used for obesity [15]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.